Michael S. Baum, MD

About Me

I am a cardiologist who specializes in cancer-related cardiovascular disease and cardiovascular toxicity related to chemotherapy and radiation.  I  evaluate cardiovascular risk in patients undergoing major cancer surgery.  My current clinical research looks at abnormal vascular function as a risk factor for cardiac events after surgery.

Plus and Minus IconIcon showing a plus/minus toggle, indicating that the surrounding element can be opened and closed.
  • Clinical Expertise: Clinical Cardiology; Nuclear Cardiology; Echocardiography; Stress Testing
  • Languages Spoken: English
  • Education: MD, University of Miami School of Medicine
  • Residencies: Beth Israel Medical Center (New York)
  • Fellowships: St. Luke's-Roosevelt Hospital Center
  • Board Certifications: Internal Medicine; Cardiovascular Diseases

See My Colleagues


Visit PubMed for a full listing of Michael S. Baum’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more Arrow rightAn icon showing an arrow pointing to the right.


Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.

Learn more Arrow rightAn icon showing an arrow pointing to the right.